Fierce Biotech Homepage

HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

After exposure to lenacapavir, HIV was able to shift the structure of its protein coating to avoid the drug’s effects.
Darren Incorvaia Jan 7, 2026 2:00pm
2026 year ahead look ahead preview forecast new year

3 biopharma CEOs explain why they are 'authentically optimistic'

Jan 6, 2026 11:54am
An envelope with rejected mark Vector illustration
Favicon Fierce Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
change direction new plan alter arrows move reprioritize

Cybin alters state to become Helus Pharma for Nasdaq trip

Dec 19, 2025 10:30am
Brinsupri

Insmed's Brinsupri comes up short in rhinosinusitis trial

Dec 18, 2025 11:27am
Ramaswamy
Favicon Fierce Biotech

Ramaswamy-backed Ambros launches with $125M to develop pain med

Dec 16, 2025 1:32pm
More News

Amgen obesity marketing head Boulton departs to lead Prolynx

Dec 11, 2025 10:40am

ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma

Dec 9, 2025 7:30am
Fierce Biotech

mRNA coalition demands stable FDA leadership amid vaccine changes

Dec 5, 2025 1:36pm

12 former FDA chiefs blast Prasad's vaccine policy shake-ups

Dec 4, 2025 10:36am